Drugs & Pharmaceuticals

News and analysis on drug development, clinical evidence, regulatory approvals, pharmacology, and the science behind treatments — from small molecules to biologics.

Here are the eleven from Nature, plus two bonus picks from me.
First, let's tip our hats to the Environmental Working Group for successfully bullying Johnson & Johnson into
A pediatrician in South Carolina, Dr. Deborah Greenhouse, recently tweeted:
It is not the least bit surprising that with the legalization of marijuana, more people are using it.
Last week, a small, publicly held antibiotic biotech, Nabriva, announced that it would wind down its operations. Everyone still there lost their jobs.
The stated goal of Direct-to-Consumer (DTC) is to provide the patient/consumer with additional information to inform their “purchasing” decisions.
If there is a single lesson to be learned from three years of the pandemic, it's that if you're going to try to treat Covid with a drug, it had better be a direct-acting antiviral drug. (1)
In a new article in Nature, author Max Kozlov asks the question, "COVID drug Paxlovi
It's hardly a secret that we are living in an Orwellian nightmare where an army of malevolent busybodies are climbing all over each other in a perverse contest to see who can come up with the most grandiose ideas – the dumber the be